Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
4,834,688
Value
$3.01B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,834,688$3.01B0.1%+170,210+3.6%AddedHolders
Q1 20264,664,478$3.60B0.1%+3,670+0.1%AddedHolders
Q4 20254,660,808$3.60B0.1%−30,415−0.6%ReducedHolders
Q3 20254,691,223$2.64B0.1%−140,779−2.9%ReducedHolders
Q2 20254,832,002$2.54B0.1%+42,343+0.9%AddedHolders
Q1 20254,789,659$3.04B0.1%−42,580−0.9%ReducedHolders
Q4 20244,832,239$3.44B0.1%−70,165−1.4%ReducedHolders
Q3 20244,902,404$5.15B0.2%+61,277+1.3%AddedHolders
Q2 20244,841,127$5.09B0.2%−4210.0%ReducedHolders
Q1 20244,841,548$4.66B0.2%−59,703−1.2%ReducedHolders
Q4 20234,901,251$4.30B0.2%+72,145+1.5%AddedHolders
Q3 20234,829,106$3.97B0.2%−161,764−3.2%ReducedHolders
Q2 20234,990,870$3.59B0.2%+97,254+2.0%AddedHolders
Q1 20234,893,616$4.02B0.2%−67,269−1.4%ReducedHolders
Q4 20224,960,885$3.58B0.2%−90,874−1.8%ReducedHolders
Q3 20225,051,759$3.48B0.2%−78,876−1.5%ReducedHolders
Q2 20225,130,635$3.03B0.2%+5,168+0.1%AddedHolders
Q1 20225,125,467$3.58B0.2%+325,645+6.8%AddedHolders
Q4 20214,799,822$3.03B0.1%+159,817+3.4%AddedHolders
Q3 20214,640,005$2.81B0.1%+123,289+2.7%AddedHolders
Q2 20214,516,716$2.52B0.1%−30,585−0.7%ReducedHolders
Q1 20214,547,301$2.15B0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.